Expertise in
8
conditions

Zwi N. Berneman

Edegem, VLG, BE 
Expertise in
8
conditions
Edegem, VLG, BE 

Overview

Zwi Berneman practices practicing medicine in Edegem, Belgium.

Berneman is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Wilms Tumor, WT1-Related Wilms Tumor Syndromes, Febrile Neutropenia, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 149 peer reviewed articles and participating in 2 clinical trials.

Locations

Edegem, VLG, Belgium
Other Locations
Antwerpen, VLG, Belgium
Wilrijk, VLG, Belgium
Universitair Ziekenhuis Leuven
Leuven, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Wilms' Tumor (WT1) Antigen-targeted Dendritic Cell Vaccination to Prevent Relapse in Adult Patients With Acute Myeloid Leukemia: a Multicenter Randomized Phase II Trial
Wilms' Tumor (WT1) Antigen-targeted Dendritic Cell Vaccination to Prevent Relapse in Adult Patients With Acute Myeloid Leukemia: a Multicenter Randomized Phase II Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 12, 2024
Intervention Type: Biological
Study Drug: Autologous WT1 mRNA-Electroporated Dendritic Cell Vaccine
Study Phase: Phase 2
10-day Decitabine Versus Conventional Chemotherapy (3+7) Followed by Allografting in AML Patients ≥ 60 Years: a Randomized Phase III Study of the EORTC Leukemia Group, CELG, GIMEMA and German MDS Study Group
10-day Decitabine Versus Conventional Chemotherapy (3+7) Followed by Allografting in AML Patients ≥ 60 Years: a Randomized Phase III Study of the EORTC Leukemia Group, CELG, GIMEMA and German MDS Study Group
Enrollment Status: Unknown
Publish Date: February 15, 2023
Intervention Type: Drug
Study Drugs: Decitabine, Daunorubicin, Cytarabine, Idarubicin, Etoposide
Study Phase: Phase 3
View 1 Less Clinical Trial

149 Total Publications

Proteomics in Acute Myeloid Leukemia: Current Applications in Precision Medicine and Targeted Immunotherapy.
Proteomics in Acute Myeloid Leukemia: Current Applications in Precision Medicine and Targeted Immunotherapy.
Journal: Technology in cancer research & treatment
Published: June 29, 2026

Frequently Asked Questions about Zwi N. Berneman

Is Zwi N. Berneman a top-rated expert for Wilms Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Zwi N. Berneman is classified as an Elite expert for Wilms Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Zwi N. Berneman participate in research or clinical trials?

Yes. Zwi N. Berneman has published 149 articles and abstracts on conditions like Wilms Tumor. You can view a list of Zwi N. Berneman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Berneman's expertise for a condition
ConditionClose
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile